|
|
Volumn 6, Issue 1, 2014, Pages 147-153
|
|
Metallomics for drug development: A further insight into intracellular activation chemistry of a ruthenium(iii)-based anticancer drug gained using a multidimensional analytical approach
a
a
b
c
a
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASCORBIC ACID;
CAPILLARY ELECTROPHORESIS;
CHEMICAL ANALYSIS;
DISEASES;
DRUG PRODUCTS;
ELECTROSPRAY IONIZATION;
INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY;
MASS SPECTROMETERS;
PEPTIDES;
TUMORS;
ANALYTICAL APPROACH;
ANTICANCER DRUG;
CENTRAL METALS;
CLINICAL TRIAL;
DRUG DEVELOPMENT;
INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRIES (ICPMS);
REACTIVE SPECIES;
TRANSFERRIN RECEPTORS;
RUTHENIUM;
ANTINEOPLASTIC AGENT;
ASCORBIC ACID;
GLUTATHIONE;
RUTHENIUM;
ARTICLE;
CAPILLARY ELECTROPHORESIS;
CYTOSOL;
DRUG DEVELOPMENT;
ELECTROSPRAY MASS SPECTROMETRY;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
CHEMISTRY, PHARMACEUTICAL;
COORDINATION COMPLEXES;
DRUG DESIGN;
HUMANS;
METALLOPROTEINS;
METALS;
MOLECULAR STRUCTURE;
ORGANOMETALLIC COMPOUNDS;
PROTEOMICS;
RUTHENIUM;
RUTHENIUM COMPOUNDS;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
TRANSFERRIN;
|
|
EID: 84890893118
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c3mt00252g Document Type: Article |
|
Times cited : (24)
|
|
References (16)
|
